CLINICAL_TRIALS
trial_result
· 2021-03-24
Clinical Trial Update: Norketotifen for the Treatment of Uncomplicated Influenza-like Illness [Phase 2]
Summary
Phase 2 trial update for norketotifen in uncomplicated influenza-like illness has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Emergo Therapeutics, Inc. | Conditions: Influenza -Like Illness | Phase 2 | Status: COMPLETED